Long-term dupilumab therapy safe and effective in pediatric atopic dermatitis, shows meta-analysisAugust 21, 2023Atopic Dermatitis
Dupilumab maintains efficacy despite dose reduction in persistently-controlled atopic dermatitisAugust 21, 2023Atopic Dermatitis
Dupilumab + TCS confers rapid and sustained improvement in atopic dermatitis severity in children August 21, 2023Atopic Dermatitis
Early emollient bathing is tied to the development of atopic dermatitis by 2 years of ageAugust 21, 2023Atopic Dermatitis
Abrocitinib is safe and effective against difficult-to-treat atopic dermatitis in daily practiceAugust 21, 2023Atopic Dermatitis
Continuous upadacitinib treatment required to maintain skin clearance in atopic dermatitisAugust 21, 2023Atopic Dermatitis
Amlitelimab is effective and well-tolerated in atopic dermatitis inadequately controlled by topical therapiesAugust 21, 2023Atopic Dermatitis
Nemolizumab shows promise in pediatric atopic dermatitis with inadequately controlled pruritusAugust 21, 2023Atopic Dermatitis
Dermatology NewsCould a malpractice insurer drop you when you need it most?August 21, 2023Business of MedicinePractice Management
Dermatology NewsDocs using AI? Some love it, most remain waryAugust 21, 2023Business of MedicinePractice Management
Dermatology NewsYour practice was bought out by private equity: Now what?August 21, 2023Business of MedicinePractice Management
Dermatology NewsOn the trail of a new vaccine for Lyme diseaseAugust 18, 2023Infectious DiseasesMixed Topics
